Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023
Operating activities
Net income		$ 199,309	$ 120,310
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation		54,236	45,215
Amortization of intangible assets		73,698	78,934
Amortization of capitalized debt fees and original issue discount		2,592	2,902
Change in fair value of investment		2,938	0
Loss on extinguishment of debt	[1]	4,861	0
Deferred income taxes		(23,546)	(18,715)
Share-based compensation expense	[2]	38,270	30,306
Gain on disposal of assets		(34)	(538)
Other noncash charges		2,904	380
Excess tax benefits from equity awards		(642)	(920)
Net changes in operating assets and liabilities, net of acquisitions:
Accounts receivable		(120,137)	(68,975)
Inventories		73,390	101,894
Other assets		(4,348)	32,175
Accounts payable		87,343	(57,866)
Accrued wages and employee benefits		22,482	10,244
Other accrued liabilities		(11,469)	(70,622)
Net cash provided by operating activities		401,847	204,724
Investing activities
Proceeds from sale of property and equipment		144	1,933
Proceeds from beneficial interests in securitization transactions		0	2,533
Contribution to tax equity investment		(1,629)	(6,627)
Purchase of long-term investments		(37,118)	(2,592)
Proceeds from sale of long-term investment		2,000	0
Expenditures for property and equipment		(83,399)	(77,718)
Acquisition of businesses, net of cash acquired		(21,784)	(15,974)
Net cash used in investing activities		(141,786)	(98,445)
Financing activities
Proceeds from short-term borrowings		29,219	49,078
Proceeds from long-term borrowings		506,465	345,384
Repayments of short-term borrowings		(48,868)	(25,910)
Repayments of long-term borrowings and finance lease obligations		(560,644)	(233,101)
Stock repurchases		(152,743)	(100,267)
Payment of debt issuance costs		(3,616)	0
Payment of contingent acquisition consideration		0	(4,979)
Payment of deferred acquisition consideration		(7,361)	0
Purchase of additional ownership interest		(9,117)	(104,844)
Taxes paid related to equity awards		(12,268)	(10,068)
Proceeds from the exercise of stock options		12,366	7,139
Net cash used in financing activities		(246,567)	(77,568)
Effect of exchange rate changes on cash and cash equivalents		(311)	91
Net increase in cash and cash equivalents		13,183	28,802
Cash and cash equivalents at beginning of period		200,994	132,723
Cash and cash equivalents at end of period		$ 214,177	$ 161,525

[1] Represents fees paid to creditors and the write-off of the unamortized original issue discount and deferred financing costs in connection with the restructuring of the Company's Tranche B Term Loan Facility.

[2] Represents share-based compensation expense to account for stock options, restricted stock and other stock awards over their respective vesting periods.